Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DC research in Australia.

D S Ritchie1

  • 1Peter MacCallum Cancer Center, St Andrews Place, East Melbourne, Australia. David.ritchie@petermac.org

Cytotherapy
|April 28, 2007
PubMed
Summary
This summary is machine-generated.

Australian researchers have significantly advanced dendritic cell (DC) biology and clinical applications over 25 years. Their collaborative efforts span basic research to clinical trials, exploring DC roles in various diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High multiplex analysis of the immune microenvironment in bone marrow trephine samples using GeoMX™ digital spatial profiling.

Immuno-oncology technology·2022
Same author

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity.

Proceedings of the National Academy of Sciences of the United States of America·2018
Same author

Nephrotic syndrome as a complication of chronic graft-versus-host disease after allogeneic haemopoietic stem cell transplantation.

Internal medicine journal·2016
Same author

The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.

Clinical and experimental immunology·2015
Same author

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome.

Bone marrow transplantation·2015
Same author

CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells.

Immunology and cell biology·2014
Same journal

Dialysis bioreactor enables high-density, serum-free expansion of dental pulp-derived mesenchymal stromal cells with enhanced secretome.

Cytotherapy·2026
Same journal

Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?

Cytotherapy·2026
Same journal

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy.

Cytotherapy·2026
Same journal

Manufacturing strategies for prolonged CAR-T cell persistence.

Cytotherapy·2026
Same journal

Overcoming five main challenges to targeting hematologic malignancies.

Cytotherapy·2026
Same journal

Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field.

Cytotherapy·2026
See all related articles

Area of Science:

  • Immunology
  • Cell Biology
  • Translational Medicine

Background:

  • Australian researchers have a 25-year history of significant contributions to dendritic cell (DC) biology.
  • Active DC research is ongoing in major Australian centers, focusing on phylogeny, physiology, and clinical applications.
  • Research encompasses the pathophysiology of DCs in malignancy, autoimmunity, chronic viral infections, renal failure, and transplantation.

Purpose of the Study:

  • To highlight the substantial contributions of Australian researchers to dendritic cell (DC) biology and its clinical applications.
  • To showcase the breadth of DC research in Australia, from fundamental science to clinical trials.
  • To emphasize the role of collaboration in advancing DC research.

Main Methods:

  • Utilizing novel investigational tools developed in Australian laboratories.

Related Experiment Videos

  • Conducting pre-clinical and clinical research on DC pathophysiology.
  • Fostering collaborations between immunologists, clinician scientists, and clinical researchers.

    • Main Results:

    • Uncovered complexities of dendritic cell (DC) subsets.
    • Established research programs spanning in vitro and animal models.
    • Advanced DC research from basic science through clinical translation to active clinical trials.

    Conclusions:

    • Australian DC research is characterized by significant advancements and a strong collaborative culture.
    • Collaborations have facilitated the translation of DC research from basic science to clinical applications.
    • Ongoing research continues to explore the multifaceted roles of DCs in health and disease.